ArticleThe Journal of biological chemistry2026
Hepatic stearoyl-CoA desaturase 1 suppresses diet-induced hyperphagia and hepatic lipid accumulation through PPARα activation and ketone body signaling.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stearoyl-CoA desaturase 1 (SCD1) is a key enzyme in fatty acid desaturation with a well-established role in lipid metabolism, but its function in appetite regulation remains insufficiently understood. Here, we investigated whether hepatic SCD1 regulates high-fat diet (HFD)-induced lipid accumulation and feeding behavior through liver-to-brain metabolic signaling. Long-term HFD feeding suppressed hepatic scd1 expression in black seabream and zebrafish despite progressive hepatic lipid accumulation. Using liver-specific scd1-overexpressing zebrafish and peroxisome proliferator-activated receptor α (PPARα)-deficient scd1-overexpressing zebrafish, we found that hepatic scd1 overexpression attenuated HFD-induced lipid deposition and markedly suppressed food intake in both larval and adult zebrafish. These effects were accompanied by reduced agouti-related peptide expression and increased cocaine- and amphetamine-regulated transcript (cart) and gonadotropin-releasing hormone 2 expression. Mechanistically, hepatic scd1 overexpression increased palmitoylethanolamide and oleoylethanolamide levels, enhanced hepatic PPARα nuclear translocation, and activated hepatic fatty acid oxidation and ketogenesis programs. Genetic ablation of PPARα weakened the lipid-lowering effect of scd1 overexpression and partially restored orexigenic signaling. Moreover, hepatic scd1 overexpression increased hepatic 3-hydroxy-3-methylglutaryl-CoA synthase 2 (hmgcs2) mRNA expression and elevated β-hydroxybutyrate and acetoacetate levels in both the liver and brain, accompanied by reduced brain AMP-activated protein kinase α phosphorylation. Together, these findings identify hepatic SCD1 as a metabolic regulator that suppresses HFD-induced hyperphagia and lipid accumulation, involving lipid-derived PPARα signaling and ketone body-mediated brain energy sensing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.